fig4
![Leelamine suppresses cMyc expression in prostate cancer cells <i>in vitro </i>and inhibits prostate carcinogenesis <i>in vivo</i>](https://image.oaes.cc/f37f6ec6-8668-4978-a6a6-a83dc20a178b/3956.fig.4.jpg)
Figure 4. The effect of leelamine (LLM) treatment on cMyc and its targets using lysates from 22Rv1 xenografts. Western blots for cMyc, LDH-A, Cyclin D1, and GAPDH using tumor lysates from control and LLM-treated mice (A). Quantitation of cMyc, LDH-A, and Cyclin D1 expression. The results shown are mean ± SD (n = 5-6). Statistical significance was determined by Student’s t-test (B).